How do I ensure my routine patient testing with a hematology analyzer is compliant with IVD regulatory requirements?

To keep routine patient testing on a hematology analyzer compliant with IVD regulatory requirements, focus on four control areas: intended use, validation/verification, ongoing quality control, and traceability/documentation. The exact requirements depend on your country/region, but the core principles are similar.

1) Use the analyzer exactly as intended

• Confirm the analyzer is cleared/approved for your jurisdiction and the specific specimen types/tests you perform.
• Follow the manufacturer’s instructions for use (IFU) for:
  • sample collection tubes/anticoagulants
  • specimen stability and transport conditions
  • operating procedures
  • calibration and maintenance intervals
  • QC material and acceptance limits
• Do not use the analyzer outside its labeled claims unless you have completed the required internal validation and your regulatory framework permits it.

2) Perform installation and method verification/validation

Before routine patient testing:

• Complete installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ) as applicable.
• Verify key performance characteristics, such as:
  • precision
  • accuracy/bias
  • reportable range
  • carryover
  • linearity
  • reference intervals or decision limits, if needed
  • sample type equivalency, if you plan to use more than one matrix
• Document all acceptance criteria and results.
• If you modify the workflow, software, reagents, or specimen types, assess whether re-verification is needed.

3) Run quality control every day of use

Routine compliance depends heavily on QC:

• Run internal QC materials at the frequency required by the IFU and your lab policy.
• Use at least two control levels when appropriate.
• Review QC with statistical rules or established QC plans.
• Do not release patient results if QC is out of range until the issue is resolved and documented.
• Use calibrators and traceable reference materials as required by the manufacturer and applicable standards.

4) Monitor analyzer performance continuously

• Review flags, error codes, histograms, scattergrams, delta checks, and instrument alerts.
• Establish criteria for:
  • rerun
  • reflex smear review
  • specimen rejection
  • result suppression
• Investigate shifts/trends in QC and patient data.
• Maintain preventive maintenance and service records.

5) Ensure staff competency and training

• Train operators on:
  • specimen handling
  • analyzer operation
  • QC interpretation
  • troubleshooting
  • result reporting and critical value escalation
• Keep competency assessments current and documented.
• Limit use to authorized personnel.

6) Maintain complete documentation and traceability

Keep records for:

• lot numbers of reagents, calibrators, and controls
• QC charts and corrective actions
• calibration history
• maintenance logs
• service reports
• validation/verification studies
• operator training and competency
• deviations, nonconformities, and CAPA
• software/firmware versions and changes

7) Control changes to reagents, software, and hardware

Any significant change may affect compliance:

• new reagent lot
• new calibrator lot
• software update
• hardware replacement
• new collection tube type
• new site or environment Review the change against your lab’s change control procedure and repeat verification if needed.

8) Follow applicable regulations and standards

Depending on your region, relevant frameworks may include:

• EU IVDR 2017/746
• US FDA IVD regulations and CLIA requirements
• ISO 13485 for quality management systems
• ISO 15189 for medical laboratory quality and competence
• national accreditation rules or local ministry/health authority requirements

9) Have a defined nonconformance and CAPA process

If something goes wrong:

• quarantine affected results
• identify impacted patients and time window
• document root cause
• correct the issue
• implement preventive action
• revalidate if needed

Practical compliance checklist

Before releasing routine patient results, confirm:

• analyzer is approved for intended use
• staff are trained and current
• QC is in control
• calibration is valid
• maintenance is up to date
• reagent/consumable lots are accepted
• result review rules are active
• records are complete
• change control is followed

If you want, I can turn this into a one-page SOP checklist or tailor it to EU IVDR, US CLIA/FDA, or ISO 15189.